Authors/Disclosures
|
Noam Harel, MD, PhD
(James J. Peters VAMC, Icahn School of Medicine at Mount Sinai)
|
Dr. Harel has received personal compensation for serving as an employee of James J. Peters VA Medical Center. Dr. Harel has received personal compensation for serving as an employee of Icahn School of Medicine at Mount Sinai. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RubiconMD. Dr. Harel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dalton & Finegold, LLP. The institution of Dr. Harel has received research support from NIH. The institution of Dr. Harel has received research support from Craig H. Neilsen Foundation. The institution of Dr. Harel has received research support from New York State Department of Health. The institution of Dr. Harel has received research support from VA Rehabilitation Research and Development. Dr. Harel has a non-compensated relationship as a Neurology Editorial Board Member with AAN that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Member, Board of Directors with American Society of Neurorehabilitation that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Chair, AAN Spine Section with AAN that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Stephen M. Strittmatter, MD, PhD
(Yale University)
|
Dr. Strittmatter has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allyx. Dr. Strittmatter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proteowise. Dr. Strittmatter has stock in Allyx. Dr. Strittmatter has stock in Proteowise. Dr. Strittmatter has stock in ReNetX. The institution of Dr. Strittmatter has received research support from Proteowise. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. |
|
Stanley H. Appel, MD, FAAN
(Methodist Neurological Institute)
|
Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics. |